Literature DB >> 27783097

Breast cancer cells and bone marrow mesenchymal stromal cells: a regulated modulation of the breast tumor in the context of immune response.

Mehdi Najar1, Hussein Fayyad-Kazan2, Wissam H Faour3, Bassam Badran2, Fabrice Journe1, Laurence Lagneaux1.   

Abstract

OBJECTIVE: The role of direct cell-cell interactions mediating selective bone metastasis by breast cancer cells (BCCs) niche is still mostly unknown.
MATERIALS AND METHODS: Conditioned medium and direct cell-cell contacts experiments were used to investigate the effect of bone marrow-derived mesenchymal stromal cells (MSCs), osteoprogenitor-like cells (MG-63) and osteosarcoma cells (SaOS-2) on luminal-like (MCF-7) and basal-like (MDA-MB-231) BCCs flow cytometry was used to assess the purity of isolated BCCs and osteoblasts. Expression of osteoblastic markers was investigated by semi-quantitative RT-PCR. RANKL and OPG levels were measured by ELISA.
RESULTS: Conditioned medium from MSCs and osteoblasts induced the expression of osteoblastic markers in BCCs. While co-culture assays with SaOS-2 increased the expression of osteoblastic markers in MCF-7 cells, SaOS-2 cell conditioned medium increased the expression of RANKL, PTHrP, VEGF and NOGGIN in MCF-7 cells. Co-cultures with either MG-63 cells or MSCs induced OPG and MMP-2 in both tumor cell lines. Interestingly, conditioned medium from co-cultures of MSCs and MDA-MB-231 cells significantly decreased the proliferation of activated T lymphocytes which was reversed by addition of anti-OPG antibodies to the co-cultures.
CONCLUSION: Our data suggest that MSCs strongly contribute to the adaptation and invasiveness of breast cancer cells in skeletal tissues.

Entities:  

Keywords:  Bone metastasis; Breast cancer cells; Mesenchymal stromal cells; Osteoprogenitor cells

Mesh:

Substances:

Year:  2016        PMID: 27783097     DOI: 10.1007/s00011-016-1000-8

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  54 in total

1.  Induction of matrix metalloproteinases MMP-1 and MMP-2 by co-culture of breast cancer cells and bone marrow fibroblasts.

Authors:  S Saad; L J Bendall; A James; D J Gottlieb; K F Bradstock
Journal:  Breast Cancer Res Treat       Date:  2000-09       Impact factor: 4.872

Review 2.  Metastasis to bone: causes, consequences and therapeutic opportunities.

Authors:  Gregory R Mundy
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

3.  Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.

Authors:  T Kon; T J Cho; T Aizawa; M Yamazaki; N Nooh; D Graves; L C Gerstenfeld; T A Einhorn
Journal:  J Bone Miner Res       Date:  2001-06       Impact factor: 6.741

Review 4.  Role of proinflammatory cytokines in the pathophysiology of osteoarthritis.

Authors:  Mohit Kapoor; Johanne Martel-Pelletier; Daniel Lajeunesse; Jean-Pierre Pelletier; Hassan Fahmi
Journal:  Nat Rev Rheumatol       Date:  2010-11-30       Impact factor: 20.543

Review 5.  RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function.

Authors:  Michael Schoppet; Klaus T Preissner; Lorenz C Hofbauer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-04-01       Impact factor: 8.311

6.  Transcriptional program of mouse osteoclast differentiation governed by the macrophage colony-stimulating factor and the ligand for the receptor activator of NFkappa B.

Authors:  David Cappellen; Ngoc-Hong Luong-Nguyen; Sandrine Bongiovanni; Olivier Grenet; Christoph Wanke; Mira Susa
Journal:  J Biol Chem       Date:  2002-03-28       Impact factor: 5.157

7.  Mitotic quiescence, but not unique "stemness," marks the phenotype of bone metastasis-initiating cells in prostate cancer.

Authors:  Ning Wang; Freyja Docherty; Hannah K Brown; Kim Reeves; Anne Fowles; Michelle Lawson; Penelope D Ottewell; Ingunn Holen; Peter I Croucher; Colby L Eaton
Journal:  FASEB J       Date:  2015-04-17       Impact factor: 5.191

8.  T and B cells participate in bone repair by infiltrating the fracture callus in a two-wave fashion.

Authors:  Ireen Könnecke; Alessandro Serra; Thaqif El Khassawna; Claudia Schlundt; Hanna Schell; Anja Hauser; Agnes Ellinghaus; Hans-Dieter Volk; Andreas Radbruch; Georg N Duda; Katharina Schmidt-Bleek
Journal:  Bone       Date:  2014-04-08       Impact factor: 4.398

Review 9.  Osteoprotegerin in breast cancer: beyond bone remodeling.

Authors:  Michael Weichhaus; Stephanie Tsang Mui Chung; Linda Connelly
Journal:  Mol Cancer       Date:  2015-06-10       Impact factor: 27.401

10.  T cells induce pre-metastatic osteolytic disease and help bone metastases establishment in a mouse model of metastatic breast cancer.

Authors:  Ana Carolina Monteiro; Ana Carolina Leal; Triciana Gonçalves-Silva; Ana Carolina T Mercadante; Fabiola Kestelman; Sacha Braun Chaves; Ricardo Bentes Azevedo; João P Monteiro; Adriana Bonomo
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

View more
  7 in total

1.  Immunological modulation following bone marrow-derived mesenchymal stromal cells and Th17 lymphocyte co-cultures.

Authors:  Mehdi Najar; Hussein Fayyad-Kazan; Wissam H Faour; Makram Merimi; Etienne M Sokal; Catherine A Lombard; Hassan Fahmi
Journal:  Inflamm Res       Date:  2018-11-30       Impact factor: 4.575

Review 2.  StarD13: a potential star target for tumor therapeutics.

Authors:  Leila Jaafar; Zeinab Chamseddine; Mirvat El-Sibai
Journal:  Hum Cell       Date:  2020-04-09       Impact factor: 4.174

3.  Correlation of TERT and Stem Cell Markers in the Context of Human Breast Cancer.

Authors:  Umar Wazir; Mona M A W Orakzai; Tracey Amanda Martin; Wen G Jiang; Kefah Mokbel
Journal:  Cancer Genomics Proteomics       Date:  2019 Mar-Apr       Impact factor: 4.069

Review 4.  Mutual concessions and compromises between stromal cells and cancer cells: driving tumor development and drug resistance.

Authors:  Pritish Nilendu; Sachin C Sarode; Devashree Jahagirdar; Ishita Tandon; Shankargouda Patil; Gargi S Sarode; Jayanta K Pal; Nilesh Kumar Sharma
Journal:  Cell Oncol (Dordr)       Date:  2018-07-19       Impact factor: 6.730

5.  Differential regulation of rho GTPases during lung adenocarcinoma migration and invasion reveals a novel role of the tumor suppressor StarD13 in invadopodia regulation.

Authors:  Maria Al Haddad; Rayane El-Rif; Samer Hanna; Leila Jaafar; Rayanne Dennaoui; Sandra Abdellatef; Veronika Miskolci; Dianne Cox; Louis Hodgson; Mirvat El-Sibai
Journal:  Cell Commun Signal       Date:  2020-09-08       Impact factor: 5.712

Review 6.  Adipose Tissue-Derived Mesenchymal Stromal/Stem Cells, Obesity and the Tumor Microenvironment of Breast Cancer.

Authors:  Andreas Ritter; Nina-Naomi Kreis; Samira Catharina Hoock; Christine Solbach; Frank Louwen; Juping Yuan
Journal:  Cancers (Basel)       Date:  2022-08-12       Impact factor: 6.575

7.  Decidua Parietalis Mesenchymal Stem/Stromal Cells and Their Secretome Diminish the Oncogenic Properties of MDA231 Cells In Vitro.

Authors:  Yasser Basmaeil; Eman Bahattab; Abdullah Al Subayyil; Haya Bin Kulayb; Maha Alrodayyan; Mohammad Abumaree; Tanvir Khatlani
Journal:  Cells       Date:  2021-12-10       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.